Organ Preserving or Radical Surgery? A Systematic Review and Meta‐Analysis of Transanal Local Excision Versus Total Mesorectal Excision After Neoadjuvant Therapy for Rectal Cancer
Journal of Surgical Oncology · 2025-12 · 132 (8) · 1337-1355
DOI: 10.1002/jso.70116 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Surgical Oncology, online erschienen am 30.10.2025. Verfasst von Mahmood Al Dhaheri und 5 weiteren Autor:innen. Beteiligte Einrichtung: Colorectal Surgery Unit, Hamad Medical Corporation, Doha, Qatar. Hauptthemen laut MEDLINE: Rectal Neoplasms, Neoadjuvant Therapy, Organ Sparing Treatments, Transanal Endoscopic Surgery. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Background
Total mesorectal excision (TME) is the standard surgical treatment for rectal cancer. Transanal local excision (TLE) after neoadjuvant chemoradiotherapy (nCRT) is an organ‐preserving option, avoiding morbidity of TME. This study compared TLE versus TME following nCRT.
Methods
We searched Medline, PubMed, Embase, Web of Science, Scopus, Cochrane databases, Google Scholar, and CINHAL to 30 April 2025. Eligible studies were adults with nonmetastatic mid or low rectal cancer treated with nCRT followed by TLE or TME. Outcomes included local recurrence, disease free survival (DFS), overall survival (OS), and postoperative complications. Risk of bias was assessed using Cochrane RoB 2 for randomized trials and Newcastle‐Ottawa Scale (NOS) for cohorts.
Results
Nineteen studies were included. TLE was associated with higher local recurrence in cohorts (RR = 1.823; 95% CI = 1.222–2.720; p = 0.003), but no difference in RCTs (RR = 1.248; 95% CI = 0.618–2.518; p = 0.537). DFS (HR = 1.121; p = 0.174) and OS (HR = 1.032; p = 0.830) did not differ. Postoperative morbidity was lower after TLE (RR = 0.429; p = 0.005).
Conclusion
Strengths include robust search, study quality and number of patients, while heterogeneity in nCRT protocol, follow up, and complication reporting are limitations. Higher recurrence in TLE in cohorts but not in RCTs suggests safety of TLE when strict selection criteria are applied. Registration: PROSPERO CRD420251076513.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Colorectal Surgery Unit, Hamad Medical Corporation, Doha, Qatar.
- Champalimaud foundation, Lisbon, Portugal.
- College of Medicine, Qatar University, Doha, Qatar.
ORCID-Profile: Mahmood Al Dhaheri, Ali Toffaha
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Al Dhaheri, M., Mubarak, R., Toffaha, A., AbuNada, M., Parvaiz, A., & Kurer, M. (2025). Organ Preserving or Radical Surgery? A Systematic Review and Meta‐Analysis of Transanal Local Excision Versus Total Mesorectal Excision After Neoadjuvant Therapy for Rectal Cancer. Journal of Surgical Oncology, 132(8), 1337-1355. https://doi.org/10.1002/jso.70116
Vancouver
Al Dhaheri M, Mubarak R, Toffaha A, AbuNada M, Parvaiz A, Kurer M. Organ Preserving or Radical Surgery? A Systematic Review and Meta‐Analysis of Transanal Local Excision Versus Total Mesorectal Excision After Neoadjuvant Therapy for Rectal Cancer. Journal of Surgical Oncology. 2025;132(8):1337-1355. doi:10.1002/jso.70116
BibTeX
@article{AlDhaheri2025,
author = {Al Dhaheri, Mahmood and Mubarak, Reem and Toffaha, Ali and AbuNada, Mohamed and Parvaiz, Amjad and Kurer, Mohamed},
title = {Organ Preserving or Radical Surgery? A Systematic Review and Meta‐Analysis of Transanal Local Excision Versus Total Mesorectal Excision After Neoadjuvant Therapy for Rectal Cancer},
journal = {Journal of Surgical Oncology},
year = {2025},
volume = {132},
number = {8},
pages = {1337--1355},
doi = {10.1002/jso.70116}
}
EUVIMED